MRK vs CI
By Alex · Tickerpine
Merck & Co., Inc. vs The Cigna Group, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | CI |
|---|---|---|
| Price | $147.76 | $297.00 |
| Market cap | $364.26B | $78.26B |
| P/E ratio | 149.3 | 13.1 |
| ROE | 5.06% | 15.65% |
| Profit margin | 3.64% | 2.09% |
| Revenue growth | 4.70% | 5.60% |
| Dividend yield | 2.30% | 2.10% |
| Beta | 0.12 | 0.25 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs CI in plain English
- MRK is the bigger company — about 4.7× the market cap of CI.
- CI is cheaper on earnings (P/E 13.1 vs 149.3).
- CI earns a higher return on equity (16% vs 5%).
- CI is growing revenue faster (6% vs 5%).
- MRK has the higher dividend yield (2.30% vs 2.10%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
CI return calculator
See what $1,000 in The Cigna Group would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.